Objective To explore the application value of three-dimensional dynamic contrast-enhanced magnetic resonance angiography (3d DCE-MRA) of the skull and neck vessel disease.

Our trial compared PCI and CABG for treating patients with previously untreated three-vessel or left main coronary artery disease (or both).